The opinion of patients with inflammatory bowel disease on healthcare received

被引:0
|
作者
Casellas, F [1 ]
Fontanet, G [1 ]
Borruel, N [1 ]
Malagelada, JR [1 ]
机构
[1] Hosp Gen Valle Hebron, Serv Digest Dis, Unitat Atencio Crohn Colitis, Barcelona, Spain
关键词
health care; information resources; inflammatory bowel disease; ulcerative colitis; Crohn's disease;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: an item to consider in analyzing a healthcare model for a population group suffering from chronic disease is necessary health-care resources, their use, and their rating by end-users. Regarding inflammatory bowel disease (IBD), healthcare resources used by patients are numerous and varied, and yet they have been never assessed. Design: an anonymous self-rated questionnaire has been developed with 24 basic questions on overall disease, who is monitoring the patient, how are visits scheduled, need for urgent care, patient view on how control may be improved, etc. This questionnaire was sent to 393 patients who were asked to fill it out and then return it by mail. Results: two hundred and thirty-seven patients returned a filled-out questionnaire. Most patients were followed up in a hospital, and only 8.8% were being monitored by a general practitioner or area specialist. Ninety-two percent of patients reported visits were routinely scheduled irrespective of clinical status, and 79.6% of patients reported having occasionally presented to an emergency department, because of not knowing what to do or due to having no other resources available in 25.2% of times. This entails that 38% of visits to an emergency unit may be prevented with a better understanding of disease or by means of a phone call. Thirty percent of patients reported that current healthcare is inadequate in terms of contents, form, or waiting time. In all, 97.8% of patients feel that information and knowledge on their disease would help in its control, and 69.6% consider that adequate information would allow them to initiate a proper treatment before visiting their doctor. Family care is another poorly looked-after aspect that 74.6% of subjects believe would be of help in controlling their disease. Conclusions: overall, the opinion of patients with IBD on healthcare received is good; however, a number of deficiencies were detected, as is the case with insufficient information, care of family members, and healthcare resources accessibility/agility.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 50 条
  • [21] Disability in Inflammatory Bowel Disease
    Abraham, Bincy P.
    Sellin, Joseph H.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012, 41 (02) : 429 - +
  • [22] The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease
    King, Dominic
    Chandan, Joht Singh
    Thomas, Tom
    Nirantharakumar, Krishnarajah
    Reulen, Raoul C.
    Adderley, Nicola J.
    Trudgill, Nigel
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (11) : 1731 - 1739
  • [23] Patients' perceptions as an indicator of quality of care, in Greek patients with inflammatory bowel disease
    Pallis, Athanasios G.
    Kostagiolas, Petros A.
    Mouzas, Ioannis A.
    Niakas, Dimitris
    SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2009, 23 (01) : 93 - 99
  • [24] Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease
    Cars, Thomas
    Wettermark, Bjorn
    Lofberg, Robert
    Eriksson, Irene
    Sundstrom, Johan
    Lordal, Mikael
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (05): : 556 - 565
  • [25] Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK
    Kapasi, Rukshana
    Glatter, Jackie
    Lamb, Christopher A.
    Acheson, Austin G.
    Andrews, Charles
    Arnott, Ian D.
    Barrett, Kevin J.
    Bell, Graham
    Bhatnagar, Guaraang
    Bloom, Stuart
    Brookes, Matthew James
    Brown, Steven R.
    Burch, Nicola
    Burman, Andy
    Crook, Kay
    Cummings, J. R. Fraser
    Davies, Justin
    Demick, Anne
    Epstein, Jenny
    Faiz, Omar
    Feakins, Roger
    Fletcher, Melissa
    Garrick, Vikki
    Jaffray, Bruce
    Johnson, Matthew
    Keetarut, Katie
    Limdi, Jimmy
    Meade, Uchu
    Muhammed, Rafeeq
    Murdock, Andrew
    Posford, Nick
    Rowse, Georgina
    Shaw, Ian
    St Clair Jones, Anja
    Taylor, Stuart
    Weaver, Sean
    Younge, Lisa
    Hawthorne, Antony Barney
    FRONTLINE GASTROENTEROLOGY, 2020, 11 (03) : 178 - 187
  • [26] Effect of Aging on Healthcare Costs of Inflammatory Bowel Disease: A Glimpse into the Future
    van der Have, Mike
    Mangen, Marie-Josee J.
    van der Valk, Mirthe E.
    Smeets, Hugo M.
    van Bodegraven, Ad
    Dijkstra, Gerard
    Fidder, Herma H.
    de Jong, Dirk J.
    Pierik, Marieke
    Ponsioen, Cyriel Y.
    van der Meulen-de Jong, Andrea E.
    van der Woude, C. Janneke
    van de Meeberg, Paul C.
    Romberg-Camps, Marielle J. L.
    Clemens, Cees H. M.
    Jansen, Jeroen M.
    Mahmmod, Nofel
    Bolwerk, Clemens J. M.
    Vermeijden, J. Reinoud
    Siersema, Peter D.
    Leenders, Max
    Oldenburg, Bas
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (04) : 637 - 645
  • [27] Healthcare Access for Patients With Inflammatory Bowel Disease in the United States: A Survey by the Crohn's & Colitis Foundation
    Jordan, Ariel A.
    Bhat, Shubha
    Ali, Tauseef
    Brunskill, Sarah R.
    Clusen, Nancy A.
    Maltz, Ross M.
    Moise, Ced
    Sun, Xiaofan
    Thomas, Harry J.
    Ray, Cassie
    Harkins-Schwarz, Mary
    Ehrlich, Orna G.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [28] Pancreatic Involvement in Patients with Inflammatory Bowel Disease
    Triantafillidis, J. K.
    Merikas, E.
    ANNALS OF GASTROENTEROLOGY, 2010, 23 (02): : 105 - 112
  • [29] Pulmonary complications in patients with inflammatory bowel disease
    Kuzela, L
    Vavrecka, A
    Prikazska, M
    Drugda, B
    Hronec, J
    Senkova, A
    Drugdova, M
    Oltman, M
    Novotna, T
    Brezina, M
    Kratky, A
    Kristufek, P
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1714 - 1719
  • [30] Adherence to treatment in patients with inflammatory bowel disease
    Andreev, K. A.
    Gorbenko, A., V
    Skirdenko, Yu. P.
    Nikolaev, N. A.
    Livzan, M. A.
    Bikbavova, G. R.
    Fedorin, M. M.
    BYULLETEN SIBIRSKOY MEDITSINY, 2021, 20 (03): : 120 - 128